Intestinal HIF2α promotes tissue-iron accumulation in disorders of iron overload with anemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 50, 2013, Pages

  Anderson, Erik R ^a   Taylor, Matthew ^a   Xue, Xiang ^a   Ramakrishnan, Sadeesh K ^a   Martin, Angelical ^a,c   Xie, Liwei ^a   Bredell, Bryce X ^a   Gardenghi, Sara ^b   Rivella, Stefano ^b   Shah, Yatrik M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Epas1; HIF; Slc11a2; Thalassemia

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 2ALPHA; IRON; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DISEASE COURSE; HEMOLYSIS; IRON ABSORPTION; IRON OVERLOAD; LIVER; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; THALASSEMIA INTERMEDIA;

EID: 84890288632     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1314197110     Document Type: Article

References (53)

1. Gattermann N (2009) The treatment of secondary hemochromatosis. Dtsch Arztebl Int 106(30):499-504, I.
2. Musallam KM, et al. (2011) Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia. Haematologica 96(11):1605-1612.
3. Steinberg MHFB, Higgs DR, Nagel RL (2001) Disorders of Hemoglobin: Genetics, Pathophysiology and Clincal Management (Cambridge Univ Press, Cambridge, UK).
4. Heinrich HC, et al. (1973) Absorption of inorganic and food iron in children with heterozygous and homozygous beta-thalassemia. Z Kinderheilkd 115(1):1-22.
5. Pitcher CS, Williams HS, Parsonson A, Williams R (1965) The measurement of iron absorption by the double isotope technique. Br J Haematol 11(6):633-641.
6. Ginzburg Y, Rivella S (2011) β-thalassemia: A model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 118(16):4321-4330.
7. Nicolas G, et al. (2001) Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci USA 98(15):8780-8785.
8. Nicolas G, et al. (2002) Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci USA 99(7):4596-4601.
9. Abboud S, Haile DJ (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275(26):19906-19912.
10. Donovan A, et al. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403(6771):776-781.
11. Donovan A, et al. (2005) The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab 1(3):191-200.
12. McKie AT, et al. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5(2):299-309.
13. Nemeth E, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306(5704):2090-2093.
14. Knutson MD, Oukka M, Koss LM, Aydemir F, Wessling-Resnick M (2005) Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 over-expression and down-regulated by hepcidin. Proc Natl Acad Sci USA 102(5):1324-1328.
15. Frazer DM, et al. (2002) Hepcidin expression inversely correlates with the expression of duodenal iron transporters and iron absorption in rats. Gastroenterology 123(3):835-844.
16. Adamsky K, et al. (2004) Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol 124(1):123-124.
17. Darshan D, Frazer DM, Anderson GJ (2010) Molecular basis of iron-loading disorders. Expert Rev Mol Med 12:e36.
18. Anderson ER, Shah YM (2013) Iron homeostasis in the liver. Compr Physiol 3(1):315-330.
19. Tanno T, et al. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13(9):1096-1101.
20. Tanno T, et al. (2009) Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114(1):181-186.
21. Gardenghi S, et al. (2010) Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice. J Clin Invest 120(12):4466-4477.
22. Guo S, et al. (2013) Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice. J Clin Invest 123(4):1531-1541.
23. Schmidt PJ, et al. (2013) An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine β-thalassemia intermedia. Blood 121(7):1200-1208.
24. Xue X, et al. (2012) Hypoxia-inducible factor-2α activation promotes colorectal cancer progression by dysregulating iron homeostasis. Cancer Res 72(9):2285-2293.
25. Taylor M, et al. (2011) Hypoxia-inducible factor-2α mediates the adaptive increase of intestinal ferroportin during iron deficiency in mice. Gastroenterology 140(7):2044-2055.
26. Shah YM, Matsubara T, Ito S, Yim SH, Gonzalez FJ (2009) Intestinal hypoxia-inducible transcription factors are essential for iron absorption following iron deficiency. Cell Metab 9(2):152-164.
27. Anderson ER, Xue X, Shah YM (2011) Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis. J Biol Chem 286(22):19533-19540.
28. Mastrogiannaki M, et al. (2012) Deletion of HIF-2α in the enterocytes decreases the severity of tissue iron loading in hepcidin knockout mice. Blood 119(2):587-590.
29. Mastrogiannaki M, et al. (2009) HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J Clin Invest 119(5):1159-1166.
30. Majmundar AJ, Wong WJ, Simon MC (2010) Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 40(2):294-309.
31. Mackenzie B, Garrick MD (2005) Iron Imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gastrointest Liver Physiol 289(6):G981-G986.
32. Latunde-Dada GO, Simpson RJ, McKie AT (2008) Duodenal cytochrome B expression stimulates iron uptake by human intestinal epithelial cells. J Nutr 138(6):991-995.
33. McKie AT, et al. (2001) An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291(5509):1755-1759.
34. Fleming MD, et al. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 16(4):383-386.
35. Gunshin H, et al. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388(6641):482-488.
36. Rivella S, May C, Chadburn A, Rivière I, Sadelain M (2003) A novel murine model of Cooley anemia and its rescue by lentiviral-mediated human beta-globin gene transfer. Blood 101(8):2932-2939.
37. Ciavatta DJ, Ryan TM, Farmer SC, Townes TM (1995) Mouse model of human beta zero thalassemia: Targeted deletion of the mouse beta maj- and beta min-globin genes in embryonic stem cells. Proc Natl Acad Sci USA 92(20):9259-9263.
38. Yang B, et al. (1995) A mouse model for beta 0-thalassemia. Proc Natl Acad Sci USA 92 (25):11608-11612.
39. Rechavi G, Rivella S (2008) Regulation of iron absorption in hemoglobinopathies. Curr Mol Med 8(7):646-662.
40. Anderson ER, et al. (2012) The hypoxia-inducible factor-C/EBṔ axis controls ethanol-mediated hepcidin repression. Mol Cell Biol 32(19):4068-4077.
41. Origa R, et al. (2007) Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 92(5):583-588.
42. Gardenghi S, et al. (2007) Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109(11):5027-5035.
43. Zhang Z, et al. (2011) Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood 118(7):1912-1922.
44. Latunde-Dada GO, McKie AT, Simpson RJ (2006) Animal models with enhanced erythropoiesis and iron absorption. Biochim Biophys Acta 1762(4):414-423.
45. Scheuermann TH, et al. (2013) Allosteric inhibition of hypoxia inducible factor-2 with small molecules. Nat Chem Biol 9(4):271-276.
46. Key J, Scheuermann TH, Anderson PC, Daggett V, Gardner KH (2009) Principles of ligand binding within a completely buried cavity in HIF2alpha PAS-B. J Am Chem Soc 131(48):17647-17654.
47. Scheuermann TH, et al. (2009) Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor. Proc Natl Acad Sci USA 106(2):450-455.
48. Li H, et al. (2010) Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med 16(2):177-182.
49. Buckett PD, Wessling-Resnick M (2009) Small molecule inhibitors of divalent metal transporter-1. Am J Physiol Gastrointest Liver Physiol 296(4):G798-G804.
50. Zhang Z, et al. (2012) Discovery of benzylisothioureas as potent divalent metal transporter 1 (DMT1) inhibitors. Bioorg Med Chem Lett 22(15):5108-5113.
51. Gunshin H, et al. (2005) Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest 115(5):1258-1266.
52. el Marjou F, et al. (2004) Tissue-specific and inducible Cre-mediated recombination in the gut epithelium. Genesis 39(3):186-193.
53. Rebouche CJ, Wilcox CL, Widness JA (2004) Microanalysis of non-heme iron in animal tissues. J Biochem Biophys Methods 58(3):239-251.